Action Biophytis - ALBPS

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,15

Prix Achat

0,1484

Prix Vente

0,155

Volume échangé

98 360

0,1482 Fourchette du Jour 0,156

0,145 Plage de 52 semaines 1,40

Cap du marché

44,355M

Clôture Veille

0,15

Ouverture

0,156

Dernière Transaction

215

0.15

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

138 478

Actions en circulation

295 702 507

Rendement du Dividende

Ratio Cours sur Bénéfices

-2,60

Bénéfice par action (BPA)

-0,06

Chiffre d'affairess

Bénéfice net

-17,03M

Secteur

Biological Pds,ex Diagnstics

Industrie

Biological Pds,ex Diagnstics

Site Web

www.biophytis.com

Siège social

Paris, Paris, Fra

Fondé

Biophytis est coté dans le secteur Biological Pds,ex Diagnstics de la Euronext avec le ticker ALBPS. Le dernier cours de clôture d'Biophytis était de 0,15 €. Au cours de la dernière année, les actions de Biophytis ont été négociées dans une fourchette de prix de 0,145 € à 1,40 €.

Biophytis compte actuellement 295 702 507 actions en circulation. La capitalisation boursière d'Biophytis est de 44,36 € million. Biophytis a un ratio cours/bénéfice (ratio PE) de -2.60.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth...

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a...

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

PARIS, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.005	-3.22580645161	0.155	0.1644	0.145	146804	0.14908437	DE
4	-0.0254	-14.4811858609	0.1754	0.18	0.145	130895	0.15995119	DE
12	-0.167	-52.6813880126	0.317	0.404	0.145	138478	0.21929511	DE
26	-0.14	-48.275862069	0.29	0.46	0.145	111049	0.25935073	DE
52	-0.65	-81.25	0.8	1.4	0.145	82147	0.3660305	DE
156	0.015	11.1111111111	0.135	1.4	0.0021	5740247	0.02007125	DE
260	-0.86	-85.1485148515	1.01	1.778	0.0021	4693947	0.22470338	DE

ALBPS - Frequently Asked Questions (FAQ)

What is the current Biophytis share price?

The current share price of Biophytis is 0,15 €

How many Biophytis shares are in issue?

Biophytis has 295 702 507 shares in issue

What is the market cap of Biophytis?

The market capitalisation of Biophytis is EUR 44,36M

What is the 1 year trading range for Biophytis share price?

Biophytis has traded in the range of 0,145 € to 1,40 € during the past year

What is the PE ratio of Biophytis?

The price to earnings ratio of Biophytis is -2,6

What is the reporting currency for Biophytis?

Biophytis reports financial results in EUR

What is the latest annual profit for Biophytis?

The latest annual profit of Biophytis is EUR -17,03M

What is the registered address of Biophytis?

The registered address for Biophytis is 14 AVENUE DE L’OPERA, PARIS, PARIS, 75001

What is the Biophytis website address?

The website address for Biophytis is www.biophytis.com

Which industry sector does Biophytis operate in?

Biophytis operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALEXPOne Experience	1,28 € (56,10%)	1,76M
MLCOTCoretech 5	0,05 € (25,00%)	82,4k
MLGALGaleo Concept	1,69 € (21,58%)	40
ALKLKKerlink	0,82 € (20,59%)	151,49k
FCPFc Do Porto	1,10 € (19,57%)	28,02k
ALFLOFlorentaise SA	0,85 € (-61,19%)	1,13k
ALCBICrypto Blockchain Industries	0,47 € (-31,88%)	2,86M
ALBOOBOOSTHEAT	0,001 € (-28,57%)	7,47M
FPGUnion Tech Info	0,0656 € (-27,75%)	1,92k
ALTBGBlockchain GP	2,25 € (-25,99%)	11,37M
ALVERVergnet	0,0006 € (0,00%)	441,52M
ALCYBCybergun	0,0002 € (0,00%)	90,84M
BCPBanco Comercial Portugues SA	0,6426 € (1,13%)	82,26M
ALALOAcheterLouerFR	0,0004 € (0,00%)	64,04M
ALEUPEuroplasma	0,0083 € (-9,78%)	37,33M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biophytis (ALBPS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Biophytis

ALBPS Dernières nouvelles

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Biophytis to Restate Previously Issued Financial Statements

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

Biophytis Announces Results of 2019 Annual General Meeting of Shareholders

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)

Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer

Biophytis Announces Publication of its 2018 Annual Report

Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States

Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

ALBPS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biophytis (ALBPS) Cours

Biophytis (ALBPS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Biophytis

ALBPS Dernières nouvelles

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Biophytis to Restate Previously Issued Financial Statements

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

Biophytis Announces Results of 2019 Annual General Meeting of Shareholders

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)

Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer

Biophytis Announces Publication of its 2018 Annual Report

Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States

Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

ALBPS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités